Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127870251 | 12787025 | 1 | I | 201609 | 20160919 | 20160927 | 20160927 | EXP | BR-ASTRAZENECA-2016SF00860 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160928 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127870251 | 12787025 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | 0 | TABLET | ||||||||||
127870251 | 12787025 | 2 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
127870251 | 12787025 | 3 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | UNI???O QUIMICA MANUFACTURER, 10 MG | 0 | ||||||||||
127870251 | 12787025 | 4 | C | TAMOXIFEN | TAMOXIFEN | 1 | (SANDOZ MANUFACTURER) | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127870251 | 12787025 | 2 | Blood pressure abnormal |
127870251 | 12787025 | 3 | Blood pressure abnormal |
127870251 | 12787025 | 4 | Polyp |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127870251 | 12787025 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127870251 | 12787025 | Blood pressure increased | |
127870251 | 12787025 | Carotid artery occlusion | |
127870251 | 12787025 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |